ID   POLG_HCVBK              Reviewed;        3010 AA.
AC   P26663;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   22-JUL-2015, entry version 175.
DE   RecName: Full=Genome polyprotein;
DE   Contains:
DE     RecName: Full=Core protein p21;
DE     AltName: Full=Capsid protein C;
DE     AltName: Full=p21;
DE   Contains:
DE     RecName: Full=Core protein p19;
DE   Contains:
DE     RecName: Full=Envelope glycoprotein E1;
DE     AltName: Full=gp32;
DE     AltName: Full=gp35;
DE   Contains:
DE     RecName: Full=Envelope glycoprotein E2;
DE     AltName: Full=NS1;
DE     AltName: Full=gp68;
DE     AltName: Full=gp70;
DE   Contains:
DE     RecName: Full=p7;
DE   Contains:
DE     RecName: Full=Protease NS2-3;
DE              Short=p23;
DE              EC=3.4.22.-;
DE   Contains:
DE     RecName: Full=Serine protease NS3;
DE              EC=3.4.21.98;
DE              EC=3.6.1.15;
DE              EC=3.6.4.13;
DE     AltName: Full=Hepacivirin;
DE     AltName: Full=NS3P;
DE     AltName: Full=p70;
DE   Contains:
DE     RecName: Full=Non-structural protein 4A;
DE              Short=NS4A;
DE     AltName: Full=p8;
DE   Contains:
DE     RecName: Full=Non-structural protein 4B;
DE              Short=NS4B;
DE     AltName: Full=p27;
DE   Contains:
DE     RecName: Full=Non-structural protein 5A;
DE              Short=NS5A;
DE     AltName: Full=p56;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase;
DE              EC=2.7.7.48;
DE     AltName: Full=NS5B;
DE     AltName: Full=p68;
OS   Hepatitis C virus genotype 1b (isolate BK) (HCV).
OC   Viruses; ssRNA viruses; ssRNA positive-strand viruses, no DNA stage;
OC   Flaviviridae; Hepacivirus.
OX   NCBI_TaxID=11105;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=1847440;
RA   Takamizawa A., Mori C., Fuke I., Manabe S., Murakami S., Fujita J.,
RA   Onishi E., Andoh T., Yoshida I., Okayama H.;
RT   "Structure and organization of the hepatitis C virus genome isolated
RT   from human carriers.";
RL   J. Virol. 65:1105-1113(1991).
RN   [2]
RP   PROTEIN SEQUENCE OF 1487-1500.
RX   PubMed=8647104; DOI=10.1111/j.1432-1033.1996.0611p.x;
RA   Borowski P., Heiland M., Oehlmann K., Becker B., Korneteky L.;
RT   "Non-structural protein 3 of hepatitis C virus inhibits
RT   phosphorylation mediated by cAMP-dependent protein kinase.";
RL   Eur. J. Biochem. 237:611-618(1996).
RN   [3]
RP   SUBCELLULAR LOCATION, AND RNA-BINDING ACTIVITY OF CORE PROTEIN.
RX   PubMed=8189501;
RA   Santolini E., Migliaccio G., La Monica N.;
RT   "Biosynthesis and biochemical properties of the hepatitis C virus core
RT   protein.";
RL   J. Virol. 68:3631-3641(1994).
RN   [4]
RP   CHARACTERIZATION OF PROTEASE NS2-3.
RX   PubMed=9261354;
RA   Pieroni L., Santolini E., Fipaldini C., Pacini L., Migliaccio G.,
RA   La Monica N.;
RT   "In vitro study of the NS2-3 protease of hepatitis C virus.";
RL   J. Virol. 71:6373-6380(1997).
RN   [5]
RP   FUNCTION OF NS5A.
RX   PubMed=9710605;
RA   Gale M.J. Jr., Blakely C.M., Kwieciszewski B., Tan S.-L., Dossett M.,
RA   Tang N.M., Korth M.J., Polyak S.J., Gretch D.R., Katze M.G.;
RT   "Control of PKR protein kinase by hepatitis C virus nonstructural 5A
RT   protein: molecular mechanisms of kinase regulation.";
RL   Mol. Cell. Biol. 18:5208-5218(1998).
RN   [6]
RP   INTERACTION OF NS5A WITH HUMAN GRB2, AND MUTAGENESIS OF PRO-2322;
RP   PRO-2323 AND PRO-2326.
RX   PubMed=10318918; DOI=10.1073/pnas.96.10.5533;
RA   Tan S.-L., Nakao H., He Y., Vijaysri S., Neddermann P., Jacobs B.L.,
RA   Mayer B.J., Katze M.G.;
RT   "NS5A, a nonstructural protein of hepatitis C virus, binds growth
RT   factor receptor-bound protein 2 adaptor protein in a Src homology 3
RT   domain/ligand-dependent manner and perturbs mitogenic signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:5533-5538(1999).
RN   [7]
RP   MUTAGENESIS OF SER-2194.
RX   PubMed=11118372; DOI=10.1006/viro.2000.0662;
RA   Katze M.G., Kwieciszewski B., Goodlett D.R., Blakely C.M.,
RA   Neddermann P., Tan S.-L., Aebersold R.;
RT   "Ser(2194) is a highly conserved major phosphorylation site of the
RT   hepatitis C virus nonstructural protein NS5A.";
RL   Virology 278:501-513(2000).
RN   [8]
RP   CHARACTERIZATION OF PROTEASE NS2-3.
RX   PubMed=11591719; DOI=10.1074/jbc.M108266200;
RA   Thibeault D., Maurice R., Pilote L., Lamarre D., Pause A.;
RT   "In vitro characterization of a purified NS2/3 protease variant of
RT   hepatitis C virus.";
RL   J. Biol. Chem. 276:46678-46684(2001).
RN   [9]
RP   INTERACTION OF NS5A WITH HUMAN PIK3R1.
RX   PubMed=12186904; DOI=10.1128/JVI.76.18.9207-9217.2002;
RA   He Y., Nakao H., Tan S.-L., Polyak S.J., Neddermann P., Vijaysri S.,
RA   Jacobs B.L., Katze M.G.;
RT   "Subversion of cell signaling pathways by hepatitis C virus
RT   nonstructural 5A protein via interaction with Grb2 and P85
RT   phosphatidylinositol 3-kinase.";
RL   J. Virol. 76:9207-9217(2002).
RN   [10]
RP   DOMAINS CD81-BINDING AND HVR2.
RX   PubMed=12660945; DOI=10.1086/368221;
RA   Hofmann W.P., Sarrazin C., Kronenberger B., Schonberger B., Bruch K.,
RA   Zeuzem S.;
RT   "Mutations within the CD81-binding sites and hypervariable region 2 of
RT   the envelope 2 protein: correlation with treatment response in
RT   hepatitis C virus-infected patients.";
RL   J. Infect. Dis. 187:982-987(2003).
RN   [11]
RP   PHOSPHORYLATION OF NS5A.
RX   PubMed=15016873; DOI=10.1128/JVI.78.7.3502-3513.2004;
RA   Coito C., Diamond D.L., Neddermann P., Korth M.J., Katze M.G.;
RT   "High-throughput screening of the yeast kinome: identification of
RT   human serine/threonine protein kinases that phosphorylate the
RT   hepatitis C virus NS5A protein.";
RL   J. Virol. 78:3502-3513(2004).
RN   [12]
RP   DOMAINS ISDR AND V3 REGIONS.
RX   PubMed=15258967; DOI=10.1002/jmv.20144;
RA   Vuillermoz I., Khattab E., Sablon E., Ottevaere I., Durantel D.,
RA   Vieux C., Trepo C., Zoulim F.;
RT   "Genetic variability of hepatitis C virus in chronically infected
RT   patients with viral breakthrough during interferon-ribavirin
RT   therapy.";
RL   J. Med. Virol. 74:41-53(2004).
RN   [13]
RP   INTERACTION OF NS5A WITH CELLULAR PROTEINS.
RX   PubMed=15607035;
RA   Ahn J., Chung K.-S., Kim D.-U., Won M., Kim L., Kim K.-S., Nam M.,
RA   Choi S.-J., Kim H.-C., Yoon M., Chae S.-K., Hoe K.-L.;
RT   "Systematic identification of hepatocellular proteins interacting with
RT   NS5A of the hepatitis C virus.";
RL   J. Biochem. Mol. Biol. 37:741-748(2004).
RN   [14]
RP   INTERACTION OF NS5A WITH HUMAN BIN1, AND FUNCTION OF NS5A.
RX   PubMed=16530520; DOI=10.1053/j.gastro.2005.12.030;
RA   Nanda S.K., Herion D., Liang T.J.;
RT   "The SH3 binding motif of HCV NS5A protein interacts with Bin1 and is
RT   important for apoptosis and infectivity.";
RL   Gastroenterology 130:794-809(2006).
RN   [15]
RP   SUBCELLULAR LOCATION OF CORE PROTEIN, AND FUNCTION OF CORE PROTEIN.
RX   PubMed=17188392; DOI=10.1016/j.jhep.2006.10.019;
RA   Jackel-Cram C., Babiuk L.A., Liu Q.;
RT   "Up-regulation of fatty acid synthase promoter by hepatitis C virus
RT   core protein: genotype-3a core has a stronger effect than genotype-1b
RT   core.";
RL   J. Hepatol. 46:999-1008(2007).
RN   [16]
RP   REVIEW.
RX   PubMed=10718937; DOI=10.1046/j.1365-2893.2000.00201.x;
RA   McLauchlan J.;
RT   "Properties of the hepatitis C virus core protein: a structural
RT   protein that modulates cellular processes.";
RL   J. Viral Hepat. 7:2-14(2000).
RN   [17]
RP   REVIEW, AND SUBCELLULAR LOCATION.
RX   PubMed=14752815; DOI=10.1002/hep.20032;
RA   Penin F., Dubuisson J., Rey F.A., Moradpour D., Pawlotsky J.-M.;
RT   "Structural biology of hepatitis C virus.";
RL   Hepatology 39:5-19(2004).
RN   [18]
RP   INTERACTION WITH HNRNPA1 AND SEPT6.
RX   PubMed=17229681; DOI=10.1128/JVI.01311-06;
RA   Kim C.S., Seol S.K., Song O.-K., Park J.H., Jang S.K.;
RT   "An RNA-binding protein, hnRNP A1, and a scaffold protein, septin 6,
RT   facilitate hepatitis C virus replication.";
RL   J. Virol. 81:3852-3865(2007).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 1027-1215.
RX   PubMed=8861916; DOI=10.1016/S0092-8674(00)81350-1;
RA   Love R.A., Parge H.E., Wickersham J.A., Hostomsky Z., Habuka N.,
RA   Moomaw E.W., Adachi T., Hostomska Z.;
RT   "The crystal structure of hepatitis C virus NS3 proteinase reveals a
RT   trypsin-like fold and a structural zinc binding site.";
RL   Cell 87:331-342(1996).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1027-1206 AND 1678-1691.
RX   PubMed=9568891; DOI=10.1002/pro.5560070402;
RA   Yan Y., Li Y., Munshi S., Sardana V., Cole J.L., Sardana M.,
RA   Steinkuehler C., Tomei L., de Francesco R., Kuo L.C., Chen Z.;
RT   "Complex of NS3 protease and NS4A peptide of BK strain hepatitis C
RT   virus: a 2.2-A resolution structure in a hexagonal crystal form.";
RL   Protein Sci. 7:837-847(1998).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1216-1650.
RX   PubMed=9614113; DOI=10.1074/jbc.273.24.15045;
RA   Cho H.-S., Ha N.-C., Kang L.-W., Chung K.M., Back S.H., Jang S.K.,
RA   Oh B.-H.;
RT   "Crystal structure of RNA helicase from genotype 1b hepatitis C virus.
RT   A feasible mechanism of unwinding duplex RNA.";
RL   J. Biol. Chem. 273:15045-15052(1998).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1013-1657.
RX   PubMed=10574797; DOI=10.1016/S0969-2126(00)80025-8;
RA   Yao N., Reichert P., Taremi S.S., Prosise W.W., Weber P.C.;
RT   "Molecular views of viral polyprotein processing revealed by the
RT   crystal structure of the hepatitis C virus bifunctional protease-
RT   helicase.";
RL   Structure 7:1353-1363(1999).
RN   [23]
RP   STRUCTURE BY NMR OF 1027-1206.
RX   PubMed=10366511; DOI=10.1006/jmbi.1999.2745;
RA   Barbato G., Cicero D.O., Nardi M.C., Steinkuehler C., Cortese R.,
RA   De Francesco R., Bazzo R.;
RT   "The solution structure of the N-terminal proteinase domain of the
RT   hepatitis C virus (HCV) NS3 protein provides new insights into its
RT   activation and catalytic mechanism.";
RL   J. Mol. Biol. 289:371-384(1999).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 2420-2950.
RX   PubMed=10557268; DOI=10.1073/pnas.96.23.13034;
RA   Bressanelli S., Tomei L., Roussel A., Incitti I., Vitale R.L.,
RA   Mathieu M., De Francesco R., Rey F.A.;
RT   "Crystal structure of the RNA-dependent RNA polymerase of hepatitis C
RT   virus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:13034-13039(1999).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 2414-2989.
RX   PubMed=10504728; DOI=10.1038/13305;
RA   Lesburg C.A., Cable M.B., Ferrari E., Hong Z., Mannarino A.F.,
RA   Weber P.C.;
RT   "Crystal structure of the RNA-dependent RNA polymerase from hepatitis
RT   C virus reveals a fully encircled active site.";
RL   Nat. Struct. Biol. 6:937-943(1999).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 2420-2999.
RX   PubMed=10574802; DOI=10.1016/S0969-2126(00)80031-3;
RA   Ago H., Adachi T., Yoshida A., Yamamoto M., Habuka N., Yatsunami K.,
RA   Miyano M.;
RT   "Crystal structure of the RNA-dependent RNA polymerase of hepatitis C
RT   virus.";
RL   Structure 7:1417-1426(1999).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 2420-2955.
RX   PubMed=11884572; DOI=10.1128/JVI.76.7.3482-3492.2002;
RA   Bressanelli S., Tomei L., Rey F.A., De Francesco R.;
RT   "Structural analysis of the hepatitis C virus RNA polymerase in
RT   complex with ribonucleotides.";
RL   J. Virol. 76:3482-3492(2002).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 2420-2989 IN COMPLEX WITH A
RP   NON-NUCLEOSIDE INHIBITOR.
RX   PubMed=12509436; DOI=10.1074/jbc.M209397200;
RA   Wang M., Ng K.K.-S., Cherney M.M., Chan L., Yannopoulos C.G.,
RA   Bedard J., Morin N., Nguyen-Ba N., Alaoui-Ismaili M.H., Bethell R.C.,
RA   James M.N.G.;
RT   "Non-nucleoside analogue inhibitors bind to an allosteric site on HCV
RT   NS5B polymerase. Crystal structures and mechanism of inhibition.";
RL   J. Biol. Chem. 278:9489-9495(2003).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 2420-2995 IN COMPLEX WITH AN
RP   INHIBITOR.
RX   PubMed=12805457; DOI=10.1128/JVI.77.13.7575-7581.2003;
RA   Love R.A., Parge H.E., Yu X., Hickey M.J., Diehl W., Gao J.,
RA   Wriggers H., Ekker A., Wang L., Thomson J.A., Dragovich P.S.,
RA   Fuhrman S.A.;
RT   "Crystallographic identification of a noncompetitive inhibitor binding
RT   site on the hepatitis C virus NS5B RNA polymerase enzyme.";
RL   J. Virol. 77:7575-7581(2003).
CC   -!- FUNCTION: Core protein packages viral RNA to form a viral
CC       nucleocapsid, and promotes virion budding. Modulates viral
CC       translation initiation by interacting with HCV IRES and 40S
CC       ribosomal subunit. Also regulates many host cellular functions
CC       such as signaling pathways and apoptosis. Prevents the
CC       establishment of cellular antiviral state by blocking the
CC       interferon-alpha/beta (IFN-alpha/beta) and IFN-gamma signaling
CC       pathways and by inducing human STAT1 degradation. Thought to play
CC       a role in virus-mediated cell transformation leading to
CC       hepatocellular carcinomas. Interacts with, and activates STAT3
CC       leading to cellular transformation. May repress the promoter of
CC       p53, and sequester CREB3 and SP110 isoform 3/Sp110b in the
CC       cytoplasm. Also represses cell cycle negative regulating factor
CC       CDKN1A, thereby interrupting an important check point of normal
CC       cell cycle regulation. Targets transcription factors involved in
CC       the regulation of inflammatory responses and in the immune
CC       response: suppresses NK-kappaB activation, and activates AP-1.
CC       Could mediate apoptotic pathways through association with TNF-type
CC       receptors TNFRSF1A and LTBR, although its effect on death
CC       receptor-induced apoptosis remains controversial. Enhances TRAIL
CC       mediated apoptosis, suggesting that it might play a role in
CC       immune-mediated liver cell injury. Seric core protein is able to
CC       bind C1QR1 at the T-cell surface, resulting in down-regulation of
CC       T-lymphocytes proliferation. May transactivate human MYC, Rous
CC       sarcoma virus LTR, and SV40 promoters. May suppress the human FOS
CC       and HIV-1 LTR activity. Alters lipid metabolism by interacting
CC       with hepatocellular proteins involved in lipid accumulation and
CC       storage. Core protein induces up-regulation of FAS promoter
CC       activity, and thereby probably contributes to the increased
CC       triglyceride accumulation in hepatocytes (steatosis) (By
CC       similarity). {ECO:0000250}.
CC   -!- FUNCTION: E1 and E2 glycoproteins form a heterodimer that is
CC       involved in virus attachment to the host cell, virion
CC       internalization through clathrin-dependent endocytosis and fusion
CC       with host membrane. E1/E2 heterodimer binds to human LDLR, CD81
CC       and SCARB1/SR-BI receptors, but this binding is not sufficient for
CC       infection, some additional liver specific cofactors may be needed.
CC       The fusion function may possibly be carried by E1. E2 inhibits
CC       human EIF2AK2/PKR activation, preventing the establishment of an
CC       antiviral state. E2 is a viral ligand for CD209/DC-SIGN and
CC       CLEC4M/DC-SIGNR, which are respectively found on dendritic cells
CC       (DCs), and on liver sinusoidal endothelial cells and macrophage-
CC       like cells of lymph node sinuses. These interactions allow capture
CC       of circulating HCV particles by these cells and subsequent
CC       transmission to permissive cells. DCs act as sentinels in various
CC       tissues where they entrap pathogens and convey them to local
CC       lymphoid tissue or lymph node for establishment of immunity.
CC       Capture of circulating HCV particles by these SIGN+ cells may
CC       facilitate virus infection of proximal hepatocytes and lymphocyte
CC       subpopulations and may be essential for the establishment of
CC       persistent infection (By similarity). {ECO:0000250}.
CC   -!- FUNCTION: P7 seems to be a heptameric ion channel protein
CC       (viroporin) and is inhibited by the antiviral drug amantadine.
CC       Also inhibited by long-alkyl-chain iminosugar derivatives.
CC       Essential for infectivity (By similarity). {ECO:0000250}.
CC   -!- FUNCTION: Protease NS2-3 is a cysteine protease responsible for
CC       the autocatalytic cleavage of NS2-NS3. Seems to undergo self-
CC       inactivation following maturation (By similarity). {ECO:0000250}.
CC   -!- FUNCTION: NS3 displays three enzymatic activities: serine
CC       protease, NTPase and RNA helicase. NS3 serine protease, in
CC       association with NS4A, is responsible for the cleavages of NS3-
CC       NS4A, NS4A-NS4B, NS4B-NS5A and NS5A-NS5B. NS3/NS4A complex also
CC       prevents phosphorylation of human IRF3, thus preventing the
CC       establishment of dsRNA induced antiviral state. NS3 RNA helicase
CC       binds to RNA and unwinds dsRNA in the 3' to 5' direction, and
CC       likely RNA stable secondary structure in the template strand.
CC       Cleaves and inhibits the host antiviral protein MAVS (By
CC       similarity). {ECO:0000250}.
CC   -!- FUNCTION: NS4B induces a specific membrane alteration that serves
CC       as a scaffold for the virus replication complex. This membrane
CC       alteration gives rise to the so-called ER-derived membranous web
CC       that contains the replication complex (By similarity).
CC       {ECO:0000250}.
CC   -!- FUNCTION: NS5A is a component of the replication complex involved
CC       in RNA-binding. Its interaction with Human VAPB may target the
CC       viral replication complex to vesicles. Down-regulates viral IRES
CC       translation initiation. Mediates interferon resistance, presumably
CC       by interacting with and inhibiting human EIF2AK2/PKR. Seems to
CC       inhibit apoptosis by interacting with BIN1 and FKBP8. The
CC       hyperphosphorylated form of NS5A is an inhibitor of viral
CC       replication (By similarity). {ECO:0000250}.
CC   -!- FUNCTION: NS5B is an RNA-dependent RNA polymerase that plays an
CC       essential role in the virus replication. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of four peptide bonds in the viral
CC       precursor polyprotein, commonly with Asp or Glu in the P6
CC       position, Cys or Thr in P1 and Ser or Ala in P1'.
CC   -!- CATALYTIC ACTIVITY: Nucleoside triphosphate + RNA(n) = diphosphate
CC       + RNA(n+1). {ECO:0000255|PROSITE-ProRule:PRU00539}.
CC   -!- CATALYTIC ACTIVITY: NTP + H(2)O = NDP + phosphate.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per NS3 protease domain. {ECO:0000250};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per NS5A N-terminal domain. {ECO:0000250};
CC   -!- ENZYME REGULATION: Activity of auto-protease NS2-3 is dependent on
CC       zinc ions and completely inhibited by EDTA, 1,10-phenanthroline,
CC       iodocetamide and N-ethylmaleimide. According to PubMed:9261354,
CC       completely inhibited by the serine protease inhibitors TLCK and
CC       TPCK. According to PubMed:8189501, almost completely inhibited by
CC       TPCK and slightly inhibited by TLCK. Not inhibited by antipain,
CC       aprotinin, E64, PMSF and pepstatin. Also inhibited by NS2-3 and
CC       NS4A derived peptides. Serine protease NS3 is also activated by
CC       zinc ions.
CC   -!- SUBUNIT: Core protein is a homomultimer that binds the C-terminal
CC       part of E1 and interacts with numerous cellular proteins.
CC       Interaction with human STAT1 SH2 domain seems to result in
CC       decreased STAT1 phosphorylation, leading to decreased IFN-
CC       stimulated gene transcription. In addition to blocking the
CC       formation of phosphorylated STAT1, the core protein also promotes
CC       ubiquitin-mediated proteasome-dependent degradation of STAT1.
CC       Interacts with, and constitutively activates human STAT3.
CC       Associates with human LTBR and TNFRSF1A receptors and possibly
CC       induces apoptosis. Binds to human SP110 isoform 3/Sp110b, HNRPK,
CC       C1QR1, YWHAE, UBE3A/E6AP, DDX3X, APOA2 and RXRA proteins.
CC       Interacts with human CREB3 nuclear transcription protein,
CC       triggering cell transformation. May interact with human p53. Also
CC       binds human cytokeratins KRT8, KRT18, KRT19 and VIM (vimentin). E1
CC       and E2 glycoproteins form a heterodimer that binds to human LDLR,
CC       CLDN1, CD81 and SCARB1 receptors. E2 binds and inhibits human
CC       EIF2AK2/PKR. Also binds human CD209/DC-SIGN and CLEC4M/DC-SIGNR.
CC       p7 forms a homoheptamer in vitro. NS2 forms a homodimer containing
CC       a pair of composite active sites at the dimerization interface.
CC       NS2 seems to interact with all other non-structural (NS) proteins.
CC       NS4A interacts with NS3 serine protease and stabilizes its
CC       folding. NS3-NS4A complex is essential for the activation of the
CC       latter and allows membrane anchorage of NS3. NS3 interacts with
CC       human TANK-binding kinase TBK1 and MAVS. NS4B and NS5A form
CC       homodimers and seem to interact with all other non-structural (NS)
CC       proteins. NS5A also interacts with human EIF2AK2/PKR, FKBP8, GRB2,
CC       BIN1, PIK3R1, SRCAP, VAPB and with most Src-family kinases. NS5B
CC       is a homooligomer and interacts with human VAPB, HNRNPA1 and SEPT6
CC       (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9WMX2:- (xeno); NbExp=5; IntAct=EBI-6874437, EBI-6863741;
CC       P52480:Pkm (xeno); NbExp=3; IntAct=EBI-6857429, EBI-647785;
CC       Q62245:Sos1 (xeno); NbExp=2; IntAct=EBI-6857429, EBI-1693;
CC       P04637:TP53 (xeno); NbExp=9; IntAct=EBI-6838571, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Core protein p21: Host endoplasmic reticulum
CC       membrane; Single-pass membrane protein. Host mitochondrion
CC       membrane; Single-pass type I membrane protein. Host lipid droplet.
CC       Note=The C-terminal transmembrane domain of core protein p21
CC       contains an ER signal leading the nascent polyprotein to the ER
CC       membrane. Only a minor proportion of core protein is present in
CC       the nucleus and an unknown proportion is secreted.
CC   -!- SUBCELLULAR LOCATION: Core protein p19: Virion {ECO:0000250}. Host
CC       cytoplasm {ECO:0000250}. Host nucleus {ECO:0000250}. Secreted
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Envelope glycoprotein E1: Virion membrane
CC       {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.
CC       Host endoplasmic reticulum membrane {ECO:0000250}; Single-pass
CC       type I membrane protein {ECO:0000250}. Note=The C-terminal
CC       transmembrane domain acts as a signal sequence and forms a hairpin
CC       structure before cleavage by host signal peptidase. After
CC       cleavage, the membrane sequence is retained at the C-terminus of
CC       the protein, serving as ER membrane anchor. A reorientation of the
CC       second hydrophobic stretch occurs after cleavage producing a
CC       single reoriented transmembrane domain. These events explain the
CC       final topology of the protein. ER retention of E1 is leaky and, in
CC       overexpression conditions, only a small fraction reaches the
CC       plasma membrane.
CC   -!- SUBCELLULAR LOCATION: Envelope glycoprotein E2: Virion membrane
CC       {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.
CC       Host endoplasmic reticulum membrane {ECO:0000250}; Single-pass
CC       type I membrane protein {ECO:0000250}. Note=The C-terminal
CC       transmembrane domain acts as a signal sequence and forms a hairpin
CC       structure before cleavage by host signal peptidase. After
CC       cleavage, the membrane sequence is retained at the C-terminus of
CC       the protein, serving as ER membrane anchor. A reorientation of the
CC       second hydrophobic stretch occurs after cleavage producing a
CC       single reoriented transmembrane domain. These events explain the
CC       final topology of the protein. ER retention of E2 is leaky and, in
CC       overexpression conditions, only a small fraction reaches the
CC       plasma membrane.
CC   -!- SUBCELLULAR LOCATION: p7: Host endoplasmic reticulum membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Host
CC       cell membrane {ECO:0000250}. Note=The C-terminus of p7 membrane
CC       domain acts as a signal sequence. After cleavage by host signal
CC       peptidase, the membrane sequence is retained at the C-terminus of
CC       the protein, serving as ER membrane anchor. Only a fraction
CC       localizes to the plasma membrane.
CC   -!- SUBCELLULAR LOCATION: Protease NS2-3: Host endoplasmic reticulum
CC       membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Serine protease NS3: Host endoplasmic
CC       reticulum membrane {ECO:0000250}; Peripheral membrane protein
CC       {ECO:0000250}. Note=NS3 is associated to the ER membrane through
CC       its binding to NS4A.
CC   -!- SUBCELLULAR LOCATION: Non-structural protein 4A: Host endoplasmic
CC       reticulum membrane {ECO:0000305}; Single-pass type I membrane
CC       protein {ECO:0000305}. Note=Host membrane insertion occurs after
CC       processing by the NS3 protease.
CC   -!- SUBCELLULAR LOCATION: Non-structural protein 4B: Host endoplasmic
CC       reticulum membrane {ECO:0000250}; Multi-pass membrane protein
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Non-structural protein 5A: Host endoplasmic
CC       reticulum membrane {ECO:0000250}; Peripheral membrane protein
CC       {ECO:0000250}. Host cytoplasm, host perinuclear region
CC       {ECO:0000250}. Host mitochondrion {ECO:0000250}. Note=Host
CC       membrane insertion occurs after processing by the NS3 protease.
CC   -!- SUBCELLULAR LOCATION: RNA-directed RNA polymerase: Host
CC       endoplasmic reticulum membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}. Note=Host membrane insertion
CC       occurs after processing by the NS3 protease.
CC   -!- DOMAIN: The transmembrane regions of envelope E1 and E2
CC       glycoproteins are involved in heterodimer formation, ER
CC       localization, and assembly of these proteins. Envelope E2
CC       glycoprotein contain two highly variable regions called
CC       hypervariable region 1 and 2 (HVR1 and HVR2). E2 also contain two
CC       segments involved in CD81-binding. HVR1 is implicated in the
CC       SCARB1-mediated cell entry. HVR2 and CD81-binding regions may be
CC       involved in sensitivity and/or resistance to IFN-alpha therapy (By
CC       similarity). {ECO:0000250}.
CC   -!- DOMAIN: The N-terminus of NS5A acts as membrane anchor. The
CC       central part of NS5A contains a variable region called interferon
CC       sensitivity determining region (ISDR) and seems to be
CC       intrinsically disordered and interacts with NS5B and host PKR (By
CC       similarity). The C-terminus of NS5A contains a variable region
CC       called variable region 3 (V3). ISDR and V3 may be involved in
CC       sensitivity and/or resistance to IFN-alpha therapy. {ECO:0000250}.
CC   -!- DOMAIN: The SH3-binding domain of NS5A is involved in the
CC       interaction with human Bin1, GRB2 and Src-family kinases.
CC   -!- DOMAIN: The N-terminal one-third of serine protease NS3 contains
CC       the protease activity. This region contains a zinc atom that does
CC       not belong to the active site, but may play a structural rather
CC       than a catalytic role. This region is essential for the activity
CC       of protease NS2-3, maybe by contributing to the folding of the
CC       latter. The helicase activity is located in the C-terminus of NS3.
CC   -!- PTM: Specific enzymatic cleavages in vivo yield mature proteins.
CC       The structural proteins, core, E1, E2 and p7 are produced by
CC       proteolytic processing by host signal peptidases. The core protein
CC       is synthesized as a 21 kDa precursor which is retained in the ER
CC       membrane through the hydrophobic signal peptide. Cleavage by the
CC       signal peptidase releases the 19 kDa mature core protein. The
CC       other proteins (p7, NS2-3, NS3, NS4A, NS4B, NS5A and NS5B) are
CC       cleaved by the viral proteases (By similarity). {ECO:0000250}.
CC   -!- PTM: Envelope E1 and E2 glycoproteins are highly N-glycosylated.
CC       {ECO:0000250}.
CC   -!- PTM: Core protein is phosphorylated by host PKC and PKA.
CC       {ECO:0000250}.
CC   -!- PTM: NS5A is phosphorylated in a basal form termed p56. p58 is a
CC       hyperphosphorylated form of p56. p56 and p58 coexist in the cell
CC       in roughly equivalent amounts. Hyperphosphorylation is dependent
CC       on the presence of NS4A. Human AKT1, RPS6KB1/p70S6K, MAP2K1/MEK1,
CC       MAP2K6/MKK6 and CSNK1A1/CKI-alpha kinases may be responsible for
CC       NS5A phosphorylation. {ECO:0000269|PubMed:15016873}.
CC   -!- PTM: NS4B is palmitoylated. This modification may play a role in
CC       its polymerization or in protein-protein interactions (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: The N-terminus of a fraction of NS4B molecules seems to be
CC       relocated post-translationally from the cytoplasm to the ER lumen,
CC       with a 5th transmembrane segment. The C-terminus of NS2 may be
CC       lumenal with a fourth transmembrane segment (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Core protein is ubiquitinated; mediated by UBE3A and leading
CC       to core protein subsequent proteasomal degradation. {ECO:0000250}.
CC   -!- MISCELLANEOUS: Cell culture adaptation of the virus leads to
CC       mutations in NS5A, reducing its inhibitory effect on replication.
CC       {ECO:0000250}.
CC   -!- MISCELLANEOUS: Core protein exerts viral interference on hepatitis
CC       B virus when HCV and HBV coinfect the same cell, by suppressing
CC       HBV gene expression, RNA encapsidation and budding. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the hepacivirus polyprotein family.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 helicase ATP-binding domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00541}.
CC   -!- SIMILARITY: Contains 1 peptidase C18 domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU01030}.
CC   -!- SIMILARITY: Contains 1 peptidase S29 domain. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 RdRp catalytic domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00539}.
CC   -!- CAUTION: The core gene probably also codes for alternative reading
CC       frame proteins (ARFPs). Many functions depicted for the core
CC       protein might belong to the ARFPs. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=euHCVdb; Note=The European HCV database;
CC       URL="https://euhcvdb.ibcp.fr/euHCVdb/";
CC   -!- WEB RESOURCE: Name=Virus Pathogen Resource;
CC       URL="http://www.viprbrc.org/brc/home.do?decorator=flavi_hcv";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M58335; AAA72945.1; -; Genomic_RNA.
DR   PIR; A38465; GNWVTC.
DR   PDB; 1A1Q; X-ray; 2.40 A; A/B/C=1027-1215.
DR   PDB; 1BT7; NMR; -; A=1027-1206.
DR   PDB; 1C2P; X-ray; 1.90 A; A/B=2422-2989.
DR   PDB; 1CSJ; X-ray; 2.80 A; A/B=2420-2950.
DR   PDB; 1CU1; X-ray; 2.50 A; A/B=1029-1657.
DR   PDB; 1GX5; X-ray; 1.70 A; A=2420-2955.
DR   PDB; 1GX6; X-ray; 1.85 A; A=2420-2950.
DR   PDB; 1JXP; X-ray; 2.20 A; A/B=1027-1206, C/D=1678-1691.
DR   PDB; 1NHU; X-ray; 2.00 A; A/B=2420-2989.
DR   PDB; 1NHV; X-ray; 2.90 A; A/B=2420-2989.
DR   PDB; 1NS3; X-ray; 2.80 A; A/B=1029-1206, C/D=1678-1689.
DR   PDB; 1OS5; X-ray; 2.20 A; A=2420-2989.
DR   PDB; 1QUV; X-ray; 2.50 A; A=2420-2989.
DR   PDB; 2AWZ; X-ray; 2.15 A; A/B=2420-2989.
DR   PDB; 2AX0; X-ray; 2.00 A; A/B=2420-2989.
DR   PDB; 2AX1; X-ray; 2.10 A; A/B=2420-2989.
DR   PDB; 2BRK; X-ray; 2.30 A; A=2420-2955.
DR   PDB; 2BRL; X-ray; 2.40 A; A=2420-2955.
DR   PDB; 2DXS; X-ray; 2.20 A; A/B=2420-2963.
DR   PDB; 2GIQ; X-ray; 1.65 A; A/B=2421-2981.
DR   PDB; 2GIR; X-ray; 1.90 A; A/B=2421-2981.
DR   PDB; 2HAI; X-ray; 1.58 A; A=2420-2988.
DR   PDB; 2HWH; X-ray; 2.30 A; A/B=2422-2989.
DR   PDB; 2HWI; X-ray; 2.00 A; A/B=2422-2989.
DR   PDB; 2I1R; X-ray; 2.20 A; A/B=2422-2989.
DR   PDB; 2JC0; X-ray; 2.20 A; A/B=2420-2989.
DR   PDB; 2JC1; X-ray; 2.00 A; A/B=2420-2989.
DR   PDB; 2O5D; X-ray; 2.20 A; A/B=2422-2989.
DR   PDB; 2WCX; X-ray; 2.00 A; A=2420-2955.
DR   PDB; 2WHO; X-ray; 2.00 A; A/B=2420-2955.
DR   PDB; 2WRM; X-ray; 1.95 A; A=2420-2955.
DR   PDB; 2XWY; X-ray; 2.53 A; A=2420-2955.
DR   PDB; 2ZKU; X-ray; 1.95 A; A/B/C/D=2420-2989.
DR   PDB; 3BR9; X-ray; 2.30 A; A/B=2420-2989.
DR   PDB; 3BSA; X-ray; 2.30 A; A/B=2420-2989.
DR   PDB; 3BSC; X-ray; 2.65 A; A/B=2420-2989.
DR   PDB; 3CDE; X-ray; 2.10 A; A/B=2420-2989.
DR   PDB; 3CIZ; X-ray; 1.87 A; A/B=2421-2989.
DR   PDB; 3CJ0; X-ray; 1.90 A; A/B=2421-2989.
DR   PDB; 3CJ2; X-ray; 1.75 A; A/B=2421-2989.
DR   PDB; 3CJ3; X-ray; 1.87 A; A/B=2421-2989.
DR   PDB; 3CJ4; X-ray; 2.07 A; A/B=2421-2989.
DR   PDB; 3CJ5; X-ray; 1.92 A; A/B=2421-2989.
DR   PDB; 3CO9; X-ray; 2.10 A; A/B=2420-2989.
DR   PDB; 3CVK; X-ray; 2.31 A; A/B=2420-2989.
DR   PDB; 3CWJ; X-ray; 2.40 A; A/B=2420-2989.
DR   PDB; 3D28; X-ray; 2.30 A; A/B=2420-2989.
DR   PDB; 3D5M; X-ray; 2.20 A; A/B=2420-2989.
DR   PDB; 3E51; X-ray; 1.90 A; A/B=2420-2989.
DR   PDB; 3FQK; X-ray; 2.20 A; A/B=2421-2989.
DR   PDB; 3FRZ; X-ray; 1.86 A; A=2420-2989.
DR   PDB; 3G86; X-ray; 2.20 A; A/B=2421-2989.
DR   PDB; 3GYN; X-ray; 2.15 A; A/B=2420-2989.
DR   PDB; 3H2L; X-ray; 1.90 A; A/B=2420-2989.
DR   PDB; 3H59; X-ray; 2.10 A; A/B=2421-2989.
DR   PDB; 3H5S; X-ray; 2.00 A; A/B=2421-2989.
DR   PDB; 3H5U; X-ray; 1.95 A; A/B=2421-2989.
DR   PDB; 3H98; X-ray; 1.90 A; A/B=2421-2989.
DR   PDB; 3IGV; X-ray; 2.60 A; A/B=2420-2989.
DR   PDB; 3MF5; X-ray; 2.00 A; A/B=2421-2989.
DR   PDB; 3RVB; X-ray; 2.20 A; A=1186-1657.
DR   PDB; 3UA7; X-ray; 1.50 A; E/F=2321-2331.
DR   PDB; 3UDL; X-ray; 2.17 A; A/B/C/D=2420-2989.
DR   PDB; 3VQS; X-ray; 1.90 A; A/B/C/D=2420-2989.
DR   PDB; 4A92; X-ray; 2.73 A; A/B=1029-1657, A/B=1678-1690.
DR   PDB; 4B6E; X-ray; 2.46 A; A/B=1029-1657.
DR   PDB; 4B6F; X-ray; 2.89 A; A/B=1029-1657.
DR   PDB; 4B71; X-ray; 2.50 A; A/B=1029-1657.
DR   PDB; 4B73; X-ray; 2.50 A; A/B=1029-1657.
DR   PDB; 4B74; X-ray; 2.18 A; A/B=1029-1657.
DR   PDB; 4B75; X-ray; 2.53 A; A/B=1029-1655.
DR   PDB; 4B76; X-ray; 2.14 A; A/B=1029-1657.
DR   PDB; 4DGV; X-ray; 1.80 A; A=412-423.
DR   PDB; 4DGY; X-ray; 1.80 A; A=412-423.
DR   PDB; 4EO6; X-ray; 1.79 A; A/B=2422-2989.
DR   PDB; 4EO8; X-ray; 1.80 A; A/B=2422-2989.
DR   PDB; 4IH5; X-ray; 1.90 A; A/B=2421-2989.
DR   PDB; 4IH6; X-ray; 2.20 A; A/B=2421-2989.
DR   PDB; 4IH7; X-ray; 2.30 A; A/B=2421-2989.
DR   PDB; 4K8B; X-ray; 2.80 A; C/D=1678-1689.
DR   PDB; 4KAI; X-ray; 2.30 A; A/B=2420-2989.
DR   PDB; 4KB7; X-ray; 1.85 A; A/B=2420-2989.
DR   PDB; 4KBI; X-ray; 2.06 A; A/B=2420-2989.
DR   PDB; 4KE5; X-ray; 2.11 A; A/B=2420-2989.
DR   PDB; 4MIA; X-ray; 2.80 A; A/B=2421-2989.
DR   PDB; 4MIB; X-ray; 2.30 A; A/B=2421-2989.
DR   PDB; 4MK7; X-ray; 2.80 A; A/B=2421-2989.
DR   PDB; 4MK8; X-ray; 2.09 A; A/B=2421-2989.
DR   PDB; 4MK9; X-ray; 2.05 A; A/B=2421-2989.
DR   PDB; 4MKA; X-ray; 2.05 A; A/B=2421-2989.
DR   PDB; 4MKB; X-ray; 1.90 A; A/B=2421-2989.
DR   PDB; 4TN2; X-ray; 2.70 A; A=2422-2989.
DR   PDB; 8OHM; X-ray; 2.30 A; A=1216-1650.
DR   PDBsum; 1A1Q; -.
DR   PDBsum; 1BT7; -.
DR   PDBsum; 1C2P; -.
DR   PDBsum; 1CSJ; -.
DR   PDBsum; 1CU1; -.
DR   PDBsum; 1GX5; -.
DR   PDBsum; 1GX6; -.
DR   PDBsum; 1JXP; -.
DR   PDBsum; 1NHU; -.
DR   PDBsum; 1NHV; -.
DR   PDBsum; 1NS3; -.
DR   PDBsum; 1OS5; -.
DR   PDBsum; 1QUV; -.
DR   PDBsum; 2AWZ; -.
DR   PDBsum; 2AX0; -.
DR   PDBsum; 2AX1; -.
DR   PDBsum; 2BRK; -.
DR   PDBsum; 2BRL; -.
DR   PDBsum; 2DXS; -.
DR   PDBsum; 2GIQ; -.
DR   PDBsum; 2GIR; -.
DR   PDBsum; 2HAI; -.
DR   PDBsum; 2HWH; -.
DR   PDBsum; 2HWI; -.
DR   PDBsum; 2I1R; -.
DR   PDBsum; 2JC0; -.
DR   PDBsum; 2JC1; -.
DR   PDBsum; 2O5D; -.
DR   PDBsum; 2WCX; -.
DR   PDBsum; 2WHO; -.
DR   PDBsum; 2WRM; -.
DR   PDBsum; 2XWY; -.
DR   PDBsum; 2ZKU; -.
DR   PDBsum; 3BR9; -.
DR   PDBsum; 3BSA; -.
DR   PDBsum; 3BSC; -.
DR   PDBsum; 3CDE; -.
DR   PDBsum; 3CIZ; -.
DR   PDBsum; 3CJ0; -.
DR   PDBsum; 3CJ2; -.
DR   PDBsum; 3CJ3; -.
DR   PDBsum; 3CJ4; -.
DR   PDBsum; 3CJ5; -.
DR   PDBsum; 3CO9; -.
DR   PDBsum; 3CVK; -.
DR   PDBsum; 3CWJ; -.
DR   PDBsum; 3D28; -.
DR   PDBsum; 3D5M; -.
DR   PDBsum; 3E51; -.
DR   PDBsum; 3FQK; -.
DR   PDBsum; 3FRZ; -.
DR   PDBsum; 3G86; -.
DR   PDBsum; 3GYN; -.
DR   PDBsum; 3H2L; -.
DR   PDBsum; 3H59; -.
DR   PDBsum; 3H5S; -.
DR   PDBsum; 3H5U; -.
DR   PDBsum; 3H98; -.
DR   PDBsum; 3IGV; -.
DR   PDBsum; 3MF5; -.
DR   PDBsum; 3RVB; -.
DR   PDBsum; 3UA7; -.
DR   PDBsum; 3UDL; -.
DR   PDBsum; 3VQS; -.
DR   PDBsum; 4A92; -.
DR   PDBsum; 4B6E; -.
DR   PDBsum; 4B6F; -.
DR   PDBsum; 4B71; -.
DR   PDBsum; 4B73; -.
DR   PDBsum; 4B74; -.
DR   PDBsum; 4B75; -.
DR   PDBsum; 4B76; -.
DR   PDBsum; 4DGV; -.
DR   PDBsum; 4DGY; -.
DR   PDBsum; 4EO6; -.
DR   PDBsum; 4EO8; -.
DR   PDBsum; 4IH5; -.
DR   PDBsum; 4IH6; -.
DR   PDBsum; 4IH7; -.
DR   PDBsum; 4K8B; -.
DR   PDBsum; 4KAI; -.
DR   PDBsum; 4KB7; -.
DR   PDBsum; 4KBI; -.
DR   PDBsum; 4KE5; -.
DR   PDBsum; 4MIA; -.
DR   PDBsum; 4MIB; -.
DR   PDBsum; 4MK7; -.
DR   PDBsum; 4MK8; -.
DR   PDBsum; 4MK9; -.
DR   PDBsum; 4MKA; -.
DR   PDBsum; 4MKB; -.
DR   PDBsum; 4TN2; -.
DR   PDBsum; 8OHM; -.
DR   ProteinModelPortal; P26663; -.
DR   SMR; P26663; 2-45, 902-1026, 1029-1657, 1973-2003, 2008-2170, 2420-2983.
DR   IntAct; P26663; 6.
DR   MINT; MINT-6548567; -.
DR   BindingDB; P26663; -.
DR   ChEMBL; CHEMBL6040; -.
DR   euHCVdb; M58335; -.
DR   BRENDA; 2.7.7.48; 2642.
DR   BRENDA; 3.4.21.98; 2642.
DR   BRENDA; 3.6.4.13; 2642.
DR   EvolutionaryTrace; P26663; -.
DR   Proteomes; UP000007413; Genome.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0030430; C:host cell cytoplasm; IDA:AgBase.
DR   GO; GO:0044164; C:host cell cytosol; IMP:AgBase.
DR   GO; GO:0044167; C:host cell endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0044186; C:host cell lipid particle; IEA:UniProtKB-SubCell.
DR   GO; GO:0044191; C:host cell mitochondrial membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042025; C:host cell nucleus; IMP:AgBase.
DR   GO; GO:0044220; C:host cell perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0020002; C:host cell plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0044385; C:integral to membrane of host cell; IEA:UniProtKB-KW.
DR   GO; GO:0019031; C:viral envelope; IEA:UniProtKB-KW.
DR   GO; GO:0019013; C:viral nucleocapsid; IEA:UniProtKB-KW.
DR   GO; GO:0055036; C:virion membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005216; F:ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0002020; F:protease binding; IPI:AgBase.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003968; F:RNA-directed RNA polymerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0008236; F:serine-type peptidase activity; IDA:AgBase.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0075512; P:clathrin-mediated endocytosis of virus by host cell; IEA:UniProtKB-KW.
DR   GO; GO:0039654; P:fusion of virus membrane with host endosome membrane; IEA:UniProtKB-KW.
DR   GO; GO:0039520; P:induction by virus of host autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0039645; P:modulation by virus of host G1/S transition checkpoint; IEA:UniProtKB-KW.
DR   GO; GO:0039707; P:pore formation by virus in membrane of host cell; IEA:UniProtKB-KW.
DR   GO; GO:0051259; P:protein oligomerization; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IDA:GOC.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0039545; P:suppression by virus of host MAVS activity; IEA:UniProtKB-KW.
DR   GO; GO:0039563; P:suppression by virus of host STAT1 activity; IEA:UniProtKB-KW.
DR   GO; GO:0039547; P:suppression by virus of host TRAF activity; IEA:UniProtKB-KW.
DR   GO; GO:0039502; P:suppression by virus of host type I interferon-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0019087; P:transformation of host cell by virus; IEA:InterPro.
DR   GO; GO:0039694; P:viral RNA genome replication; IEA:InterPro.
DR   GO; GO:0019062; P:virion attachment to host cell; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.300; -; 2.
DR   InterPro; IPR011492; DEAD_Flavivir.
DR   InterPro; IPR002521; HCV_core_C.
DR   InterPro; IPR002522; HCV_core_N.
DR   InterPro; IPR002519; HCV_env.
DR   InterPro; IPR002531; HCV_NS1.
DR   InterPro; IPR002518; HCV_NS2.
DR   InterPro; IPR000745; HCV_NS4a.
DR   InterPro; IPR001490; HCV_NS4b.
DR   InterPro; IPR002868; HCV_NS5a.
DR   InterPro; IPR013193; HCV_NS5a_1B_dom.
DR   InterPro; IPR024350; HCV_NS5a_C.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR013192; NS5A_1a.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR004109; Peptidase_S29.
DR   InterPro; IPR007094; RNA-dir_pol_PSvirus.
DR   InterPro; IPR002166; RNA_pol_HCV.
DR   InterPro; IPR009003; Trypsin-like_Pept_dom.
DR   Pfam; PF07652; Flavi_DEAD; 1.
DR   Pfam; PF01543; HCV_capsid; 1.
DR   Pfam; PF01542; HCV_core; 1.
DR   Pfam; PF01539; HCV_env; 1.
DR   Pfam; PF01560; HCV_NS1; 1.
DR   Pfam; PF01538; HCV_NS2; 1.
DR   Pfam; PF01006; HCV_NS4a; 1.
DR   Pfam; PF01001; HCV_NS4b; 1.
DR   Pfam; PF01506; HCV_NS5a; 1.
DR   Pfam; PF08300; HCV_NS5a_1a; 1.
DR   Pfam; PF08301; HCV_NS5a_1b; 1.
DR   Pfam; PF12941; HCV_NS5a_C; 1.
DR   Pfam; PF02907; Peptidase_S29; 1.
DR   Pfam; PF00998; RdRP_3; 1.
DR   ProDom; PD001388; HCV_env; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   PROSITE; PS51693; HCV_NS2_PRO; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS50507; RDRP_SSRNA_POS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activation of host autophagy by virus;
KW   Apoptosis; ATP-binding; Capsid protein;
KW   Clathrin-mediated endocytosis of virus by host; Complete proteome;
KW   Direct protein sequencing; Disulfide bond;
KW   Fusion of virus membrane with host endosomal membrane;
KW   Fusion of virus membrane with host membrane;
KW   G1/S host cell cycle checkpoint dysregulation by virus; Glycoprotein;
KW   Helicase; Host cell membrane; Host cytoplasm;
KW   Host endoplasmic reticulum; Host lipid droplet; Host membrane;
KW   Host mitochondrion; Host nucleus; Host-virus interaction; Hydrolase;
KW   Inhibition of host innate immune response by virus;
KW   Inhibition of host interferon signaling pathway by virus;
KW   Inhibition of host MAVS by virus;
KW   Inhibition of host RLR pathway by virus;
KW   Inhibition of host STAT1 by virus; Inhibition of host TRAFs by virus;
KW   Interferon antiviral system evasion; Ion channel; Ion transport;
KW   Lipoprotein; Membrane; Metal-binding;
KW   Modulation of host cell cycle by virus; Multifunctional enzyme;
KW   Nucleotide-binding; Nucleotidyltransferase; Oncogene; Palmitate;
KW   Phosphoprotein; Protease; Ribonucleoprotein; RNA-binding;
KW   RNA-directed RNA polymerase; Secreted; Serine protease; SH3-binding;
KW   Thiol protease; Transcription; Transcription regulation; Transferase;
KW   Transmembrane; Transmembrane helix; Transport; Ubl conjugation;
KW   Viral attachment to host cell; Viral envelope protein;
KW   Viral immunoevasion; Viral ion channel; Viral nucleoprotein;
KW   Viral penetration into host cytoplasm; Viral RNA replication; Virion;
KW   Virus endocytosis by host; Virus entry into host cell; Zinc.
FT   INIT_MET      1      1       Removed; by host. {ECO:0000250}.
FT   CHAIN         2    191       Core protein p21. {ECO:0000255}.
FT                                /FTId=PRO_0000037529.
FT   CHAIN         2    177       Core protein p19. {ECO:0000250}.
FT                                /FTId=PRO_0000037530.
FT   PROPEP      178    191       ER anchor for the core protein, removed
FT                                in mature form by host signal peptidase.
FT                                {ECO:0000250}.
FT                                /FTId=PRO_0000037531.
FT   CHAIN       192    383       Envelope glycoprotein E1. {ECO:0000255}.
FT                                /FTId=PRO_0000037532.
FT   CHAIN       384    746       Envelope glycoprotein E2. {ECO:0000255}.
FT                                /FTId=PRO_0000037533.
FT   CHAIN       747    809       p7. {ECO:0000250}.
FT                                /FTId=PRO_0000037534.
FT   CHAIN       810   1026       Protease NS2-3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01030}.
FT                                /FTId=PRO_0000037535.
FT   CHAIN      1027   1657       Serine protease NS3.
FT                                /FTId=PRO_0000037536.
FT   CHAIN      1658   1711       Non-structural protein 4A.
FT                                /FTId=PRO_0000037537.
FT   CHAIN      1712   1972       Non-structural protein 4B.
FT                                /FTId=PRO_0000037538.
FT   CHAIN      1973   2419       Non-structural protein 5A.
FT                                /FTId=PRO_0000037539.
FT   CHAIN      2420   3010       RNA-directed RNA polymerase.
FT                                /FTId=PRO_0000037540.
FT   TOPO_DOM      2    168       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    169    189       Helical. {ECO:0000255}.
FT   TOPO_DOM    190    358       Lumenal. {ECO:0000255}.
FT   TRANSMEM    359    379       Helical. {ECO:0000255}.
FT   TOPO_DOM    380    725       Lumenal. {ECO:0000255}.
FT   TRANSMEM    726    746       Helical. {ECO:0000255}.
FT   TOPO_DOM    747    757       Lumenal. {ECO:0000255}.
FT   TRANSMEM    758    778       Helical. {ECO:0000255}.
FT   TOPO_DOM    779    782       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    783    803       Helical. {ECO:0000255}.
FT   TOPO_DOM    804    813       Lumenal. {ECO:0000255}.
FT   TRANSMEM    814    834       Helical. {ECO:0000255}.
FT   TOPO_DOM    835    881       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    882    902       Helical. {ECO:0000255}.
FT   TOPO_DOM    903    928       Lumenal. {ECO:0000255}.
FT   TRANSMEM    929    949       Helical. {ECO:0000255}.
FT   TOPO_DOM    950   1657       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1658   1678       Helical. {ECO:0000255}.
FT   TOPO_DOM   1679   1805       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1806   1826       Helical. {ECO:0000255}.
FT   TOPO_DOM   1827   1828       Lumenal. {ECO:0000255}.
FT   TRANSMEM   1829   1849       Helical. {ECO:0000255}.
FT   TOPO_DOM   1850   1850       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1851   1871       Helical. {ECO:0000255}.
FT   TOPO_DOM   1872   1881       Lumenal. {ECO:0000255}.
FT   TRANSMEM   1882   1902       Helical. {ECO:0000255}.
FT   TOPO_DOM   1903   1972       Cytoplasmic. {ECO:0000255}.
FT   INTRAMEM   1973   2002       {ECO:0000250}.
FT   TOPO_DOM   2003   2989       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2990   3010       Helical. {ECO:0000250}.
FT   DOMAIN      903   1026       Peptidase C18. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01030}.
FT   DOMAIN     1217   1369       Helicase ATP-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00541}.
FT   DOMAIN     2633   2751       RdRp catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00539}.
FT   NP_BIND    1230   1237       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00541}.
FT   REGION        2     59       Interaction with DDX3X. {ECO:0000250}.
FT   REGION        2     23       Interaction with STAT1. {ECO:0000250}.
FT   REGION      122    173       Interaction with APOA2. {ECO:0000250}.
FT   REGION      148    236       Interaction with FKBP8.
FT   REGION      150    159       Mitochondrial targeting signal.
FT                                {ECO:0000250}.
FT   REGION      164    167       Important for lipid droplets
FT                                localization. {ECO:0000250}.
FT   REGION      265    296       Fusion peptide. {ECO:0000255}.
FT   REGION      385    411       HVR1.
FT   REGION      475    481       HVR2.
FT   REGION      482    494       CD81-binding 1. {ECO:0000255}.
FT   REGION      522    553       CD81-binding 2. {ECO:0000255}.
FT   REGION      660    671       PKR/eIF2-alpha phosphorylation homology
FT                                domain (PePHD).
FT   REGION     1679   1690       NS3-binding (by NS4A). {ECO:0000255}.
FT   REGION     2120   2332       Transcriptional activation.
FT                                {ECO:0000255}.
FT   REGION     2120   2208       FKBP8-binding. {ECO:0000255}.
FT   REGION     2200   2250       Basal phosphorylation. {ECO:0000250}.
FT   REGION     2210   2275       PKR-binding. {ECO:0000255}.
FT   REGION     2210   2249       ISDR.
FT   REGION     2249   2306       NS4B-binding. {ECO:0000255}.
FT   REGION     2351   2419       Basal phosphorylation. {ECO:0000250}.
FT   REGION     2354   2377       V3.
FT   MOTIF         5     13       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   MOTIF        38     43       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   MOTIF        58     64       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   MOTIF        66     71       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   MOTIF      1316   1319       DECH box.
FT   MOTIF      2322   2325       SH3-binding. {ECO:0000255}.
FT   MOTIF      2327   2335       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   COMPBIAS    796    803       Poly-Leu.
FT   COMPBIAS   1432   1435       Poly-Val.
FT   COMPBIAS   2282   2327       Pro-rich.
FT   COMPBIAS   2995   2998       Poly-Leu.
FT   ACT_SITE    952    952       For protease NS2-3 activity; shared with
FT                                dimeric partner. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01030}.
FT   ACT_SITE    972    972       For protease NS2-3 activity; shared with
FT                                dimeric partner. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01030}.
FT   ACT_SITE    993    993       For protease NS2-3 activity; shared with
FT                                dimeric partner. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01030}.
FT   ACT_SITE   1083   1083       Charge relay system; for serine protease
FT                                NS3 activity. {ECO:0000250}.
FT   ACT_SITE   1107   1107       Charge relay system; for serine protease
FT                                NS3 activity. {ECO:0000250}.
FT   ACT_SITE   1165   1165       Charge relay system; for serine protease
FT                                NS3 activity. {ECO:0000250}.
FT   METAL      1123   1123       Zinc.
FT   METAL      1125   1125       Zinc.
FT   METAL      1171   1171       Zinc.
FT   METAL      1175   1175       Zinc.
FT   METAL      2011   2011       Zinc. {ECO:0000250}.
FT   METAL      2029   2029       Zinc. {ECO:0000250}.
FT   METAL      2031   2031       Zinc. {ECO:0000250}.
FT   METAL      2052   2052       Zinc. {ECO:0000250}.
FT   SITE        177    178       Cleavage; by host signal peptidase.
FT                                {ECO:0000250}.
FT   SITE        191    192       Cleavage; by host signal peptidase.
FT                                {ECO:0000255}.
FT   SITE        383    384       Cleavage; by host signal peptidase.
FT                                {ECO:0000255}.
FT   SITE        746    747       Cleavage; by host signal peptidase.
FT                                {ECO:0000250}.
FT   SITE        809    810       Cleavage; by host signal peptidase.
FT                                {ECO:0000250}.
FT   SITE       1026   1027       Cleavage; by protease NS2-3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01030}.
FT   SITE       1657   1658       Cleavage; by serine protease NS3.
FT                                {ECO:0000255}.
FT   SITE       1711   1712       Cleavage; by serine protease NS3.
FT                                {ECO:0000255}.
FT   SITE       1972   1973       Cleavage; by serine protease NS3.
FT                                {ECO:0000255}.
FT   SITE       2419   2420       Cleavage; by serine protease NS3.
FT                                {ECO:0000255}.
FT   MOD_RES       2      2       N-acetylserine; by host. {ECO:0000250}.
FT   MOD_RES      53     53       Phosphoserine; by host. {ECO:0000250}.
FT   MOD_RES      99     99       Phosphoserine; by host. {ECO:0000250}.
FT   MOD_RES     116    116       Phosphoserine; by host PKA.
FT                                {ECO:0000250}.
FT   MOD_RES    2194   2194       Phosphoserine; by host; in p56.
FT                                {ECO:0000305|PubMed:15016873}.
FT   MOD_RES    2197   2197       Phosphoserine; by host; in p58.
FT                                {ECO:0000250}.
FT   MOD_RES    2201   2201       Phosphoserine; by host; in p58.
FT                                {ECO:0000250}.
FT   MOD_RES    2204   2204       Phosphoserine; by host; in p58.
FT                                {ECO:0000250}.
FT   LIPID      1968   1968       S-palmitoyl cysteine; by host.
FT                                {ECO:0000250}.
FT   LIPID      1972   1972       S-palmitoyl cysteine; by host.
FT                                {ECO:0000250}.
FT   CARBOHYD    196    196       N-linked (GlcNAc...); by host.
FT                                {ECO:0000255}.
FT   CARBOHYD    209    209       N-linked (GlcNAc...); by host.
FT                                {ECO:0000255}.
FT   CARBOHYD    234    234       N-linked (GlcNAc...); by host.
FT                                {ECO:0000255}.
FT   CARBOHYD    250    250       N-linked (GlcNAc...); by host.
FT                                {ECO:0000255}.
FT   CARBOHYD    305    305       N-linked (GlcNAc...); by host.
FT                                {ECO:0000255}.
FT   CARBOHYD    417    417       N-linked (GlcNAc...); by host.
FT                                {ECO:0000255}.
FT   CARBOHYD    423    423       N-linked (GlcNAc...); by host.
FT                                {ECO:0000255}.
FT   CARBOHYD    430    430       N-linked (GlcNAc...); by host.
FT                                {ECO:0000255}.
FT   CARBOHYD    448    448       N-linked (GlcNAc...); by host.
FT                                {ECO:0000255}.
FT   CARBOHYD    532    532       N-linked (GlcNAc...); by host.
FT                                {ECO:0000255}.
FT   CARBOHYD    540    540       N-linked (GlcNAc...); by host.
FT                                {ECO:0000255}.
FT   CARBOHYD    556    556       N-linked (GlcNAc...); by host.
FT                                {ECO:0000255}.
FT   CARBOHYD    576    576       N-linked (GlcNAc...); by host.
FT                                {ECO:0000255}.
FT   CARBOHYD    623    623       N-linked (GlcNAc...); by host.
FT                                {ECO:0000255}.
FT   CARBOHYD    645    645       N-linked (GlcNAc...); by host.
FT                                {ECO:0000255}.
FT   DISULFID   2114   2162       {ECO:0000250}.
FT   MUTAGEN    2194   2194       S->A: Loss of phosphorylation.
FT                                {ECO:0000269|PubMed:11118372}.
FT   MUTAGEN    2322   2322       P->A: Complete loss of binding to GRB2.
FT                                {ECO:0000269|PubMed:10318918}.
FT   MUTAGEN    2323   2323       P->A: Complete loss of binding to GRB2.
FT                                {ECO:0000269|PubMed:10318918}.
FT   MUTAGEN    2326   2326       P->A: Complete loss of binding to GRB2.
FT                                {ECO:0000269|PubMed:10318918}.
FT   STRAND      413    416       {ECO:0000244|PDB:4DGY}.
FT   STRAND      419    422       {ECO:0000244|PDB:4DGY}.
FT   STRAND     1031   1035       {ECO:0000244|PDB:4B76}.
FT   HELIX      1039   1048       {ECO:0000244|PDB:4B76}.
FT   STRAND     1057   1063       {ECO:0000244|PDB:4B76}.
FT   STRAND     1068   1074       {ECO:0000244|PDB:4B76}.
FT   STRAND     1077   1080       {ECO:0000244|PDB:4B76}.
FT   HELIX      1082   1085       {ECO:0000244|PDB:4B76}.
FT   STRAND     1090   1092       {ECO:0000244|PDB:1JXP}.
FT   STRAND     1095   1097       {ECO:0000244|PDB:1JXP}.
FT   STRAND     1100   1103       {ECO:0000244|PDB:4B76}.
FT   TURN       1104   1107       {ECO:0000244|PDB:4B76}.
FT   STRAND     1108   1112       {ECO:0000244|PDB:4B76}.
FT   STRAND     1128   1133       {ECO:0000244|PDB:4B76}.
FT   STRAND     1135   1137       {ECO:0000244|PDB:1BT7}.
FT   STRAND     1139   1144       {ECO:0000244|PDB:4B76}.
FT   STRAND     1146   1157       {ECO:0000244|PDB:4B76}.
FT   HELIX      1158   1161       {ECO:0000244|PDB:4B76}.
FT   STRAND     1168   1170       {ECO:0000244|PDB:4B76}.
FT   TURN       1172   1174       {ECO:0000244|PDB:1JXP}.
FT   STRAND     1176   1186       {ECO:0000244|PDB:4B76}.
FT   STRAND     1189   1197       {ECO:0000244|PDB:4B76}.
FT   HELIX      1198   1206       {ECO:0000244|PDB:4B76}.
FT   STRAND     1224   1229       {ECO:0000244|PDB:4B76}.
FT   STRAND     1232   1235       {ECO:0000244|PDB:1CU1}.
FT   TURN       1236   1238       {ECO:0000244|PDB:4B76}.
FT   HELIX      1239   1245       {ECO:0000244|PDB:4B76}.
FT   TURN       1246   1248       {ECO:0000244|PDB:4B76}.
FT   STRAND     1251   1256       {ECO:0000244|PDB:4B76}.
FT   HELIX      1258   1270       {ECO:0000244|PDB:4B76}.
FT   STRAND     1271   1273       {ECO:0000244|PDB:4B73}.
FT   STRAND     1277   1279       {ECO:0000244|PDB:4B76}.
FT   STRAND     1290   1295       {ECO:0000244|PDB:4B76}.
FT   HELIX      1296   1301       {ECO:0000244|PDB:4B76}.
FT   STRAND     1311   1317       {ECO:0000244|PDB:4B76}.
FT   HELIX      1323   1335       {ECO:0000244|PDB:4B76}.
FT   TURN       1336   1340       {ECO:0000244|PDB:4B76}.
FT   STRAND     1342   1350       {ECO:0000244|PDB:4B76}.
FT   STRAND     1362   1366       {ECO:0000244|PDB:4B76}.
FT   STRAND     1371   1375       {ECO:0000244|PDB:4B76}.
FT   STRAND     1378   1380       {ECO:0000244|PDB:4B76}.
FT   HELIX      1383   1386       {ECO:0000244|PDB:4B76}.
FT   STRAND     1390   1393       {ECO:0000244|PDB:4B76}.
FT   HELIX      1397   1409       {ECO:0000244|PDB:4B76}.
FT   STRAND     1414   1417       {ECO:0000244|PDB:4B76}.
FT   STRAND     1419   1421       {ECO:0000244|PDB:8OHM}.
FT   HELIX      1423   1425       {ECO:0000244|PDB:3RVB}.
FT   STRAND     1428   1430       {ECO:0000244|PDB:4B76}.
FT   STRAND     1433   1436       {ECO:0000244|PDB:4B76}.
FT   HELIX      1440   1443       {ECO:0000244|PDB:4B76}.
FT   STRAND     1448   1453       {ECO:0000244|PDB:4B76}.
FT   STRAND     1456   1463       {ECO:0000244|PDB:4B76}.
FT   STRAND     1467   1469       {ECO:0000244|PDB:4B76}.
FT   STRAND     1471   1478       {ECO:0000244|PDB:4B76}.
FT   HELIX      1481   1488       {ECO:0000244|PDB:4B76}.
FT   STRAND     1493   1495       {ECO:0000244|PDB:4B76}.
FT   STRAND     1497   1503       {ECO:0000244|PDB:4B76}.
FT   STRAND     1509   1511       {ECO:0000244|PDB:4B76}.
FT   HELIX      1514   1526       {ECO:0000244|PDB:4B76}.
FT   HELIX      1532   1544       {ECO:0000244|PDB:4B76}.
FT   HELIX      1555   1563       {ECO:0000244|PDB:4B76}.
FT   HELIX      1570   1579       {ECO:0000244|PDB:4B76}.
FT   HELIX      1584   1596       {ECO:0000244|PDB:4B76}.
FT   HELIX      1606   1617       {ECO:0000244|PDB:4B76}.
FT   STRAND     1627   1629       {ECO:0000244|PDB:4B76}.
FT   STRAND     1635   1637       {ECO:0000244|PDB:8OHM}.
FT   HELIX      1640   1648       {ECO:0000244|PDB:4B76}.
FT   STRAND     1653   1656       {ECO:0000244|PDB:4B76}.
FT   STRAND     1680   1688       {ECO:0000244|PDB:1JXP}.
FT   STRAND     2421   2425       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2446   2449       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2453   2455       {ECO:0000244|PDB:2GIQ}.
FT   STRAND     2456   2458       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2461   2463       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2464   2471       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2481   2494       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2504   2509       {ECO:0000244|PDB:2GIQ}.
FT   TURN       2519   2521       {ECO:0000244|PDB:2WRM}.
FT   HELIX      2524   2528       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2532   2547       {ECO:0000244|PDB:2GIQ}.
FT   STRAND     2549   2551       {ECO:0000244|PDB:2GIQ}.
FT   STRAND     2555   2559       {ECO:0000244|PDB:2GIQ}.
FT   STRAND     2563   2565       {ECO:0000244|PDB:2GIQ}.
FT   TURN       2568   2571       {ECO:0000244|PDB:1GX5}.
FT   STRAND     2578   2581       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2584   2606       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2607   2609       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2611   2613       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2616   2629       {ECO:0000244|PDB:2GIQ}.
FT   STRAND     2630   2638       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2643   2646       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2649   2659       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2666   2678       {ECO:0000244|PDB:2GIQ}.
FT   TURN       2679   2681       {ECO:0000244|PDB:1GX6}.
FT   STRAND     2683   2686       {ECO:0000244|PDB:2GIQ}.
FT   STRAND     2688   2690       {ECO:0000244|PDB:1CSJ}.
FT   STRAND     2692   2696       {ECO:0000244|PDB:2GIQ}.
FT   STRAND     2701   2703       {ECO:0000244|PDB:2HWI}.
FT   HELIX      2706   2724       {ECO:0000244|PDB:2GIQ}.
FT   STRAND     2728   2735       {ECO:0000244|PDB:2GIQ}.
FT   STRAND     2738   2744       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2748   2764       {ECO:0000244|PDB:2GIQ}.
FT   STRAND     2769   2771       {ECO:0000244|PDB:2GIQ}.
FT   STRAND     2776   2778       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2779   2781       {ECO:0000244|PDB:2GIQ}.
FT   STRAND     2787   2793       {ECO:0000244|PDB:2GIQ}.
FT   STRAND     2795   2797       {ECO:0000244|PDB:3CVK}.
FT   STRAND     2799   2804       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2808   2819       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2826   2833       {ECO:0000244|PDB:2GIQ}.
FT   TURN       2834   2836       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2838   2842       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2844   2854       {ECO:0000244|PDB:2GIQ}.
FT   STRAND     2858   2860       {ECO:0000244|PDB:3BSA}.
FT   STRAND     2862   2866       {ECO:0000244|PDB:2GIQ}.
FT   STRAND     2869   2873       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2875   2877       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2878   2886       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2888   2891       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2898   2911       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2916   2933       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2935   2944       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2946   2948       {ECO:0000244|PDB:2GIQ}.
FT   STRAND     2949   2951       {ECO:0000244|PDB:2GIQ}.
FT   HELIX      2959   2962       {ECO:0000244|PDB:2GIQ}.
FT   TURN       2967   2970       {ECO:0000244|PDB:2GIQ}.
FT   STRAND     2976   2978       {ECO:0000244|PDB:4KE5}.
FT   STRAND     2980   2982       {ECO:0000244|PDB:4EO6}.
SQ   SEQUENCE   3010 AA;  327194 MW;  F8422D5ECCFDFD9C CRC64;
     MSTNPKPQRK TKRNTNRRPQ DVKFPGGGQI VGGVYLLPRR GPRLGVRAPR KTSERSQPRG
     RRQPIPKARR PEGRTWAQPG YPWPLYGNEG LGWAGWLLSP RGSRPSWGPT DPRRRSRNLG
     KVIDTLTCGF ADLMGYIPLV GAPLGGAARA LAHGVRVLED GVNYATGNLP GCSFSIFLLA
     LLSCLTTPAS AYEVHNVSGI YHVTNDCSNA SIVYEAADLI MHTPGCVPCV REGNSSRCWV
     ALTPTLAARN VTIPTTTIRR HVDLLVGAAA FCSAMYVGDL CGSVFLVSQL FTFSPRRHVT
     LQDCNCSIYP GHVSGHRMAW DMMMNWSPTT ALVVSQLLRI PQAVVDMVAG AHWGVLAGLA
     YYSMAGNWAK VLIVMLLFAG VDGDTHVTGG AQAKTTNRLV SMFASGPSQK IQLINTNGSW
     HINRTALNCN DSLQTGFLAA LFYTHSFNSS GCPERMAQCR TIDKFDQGWG PITYAESSRS
     DQRPYCWHYP PPQCTIVPAS EVCGPVYCFT PSPVVVGTTD RFGVPTYRWG ENETDVLLLN
     NTRPPQGNWF GCTWMNSTGF TKTCGGPPCN IGGVGNNTLT CPTDCFRKHP EATYTKCGSG
     PWLTPRCMVD YPYRLWHYPC TVNFTIFKVR MYVGGVEHRL NAACNWTRGE RCDLEDRDRP
     ELSPLLLSTT EWQVLPCSFT TLPALSTGLI HLHQNIVDVQ YLYGIGSAVV SFAIKWEYVL
     LLFLLLADAR VCACLWMMLL IAQAEAALEN LVVLNSASVA GAHGILSFLV FFCAAWYIKG
     RLVPGATYAL YGVWPLLLLL LALPPRAYAM DREMAASCGG AVFVGLVLLT LSPYYKVFLA
     RLIWWLQYFT TRAEADLHVW IPPLNARGGR DAIILLMCAV HPELIFDITK LLIAILGPLM
     VLQAGITRVP YFVRAQGLIH ACMLVRKVAG GHYVQMAFMK LGALTGTYIY NHLTPLRDWP
     RAGLRDLAVA VEPVVFSDME TKIITWGADT AACGDIILGL PVSARRGKEI LLGPADSLEG
     RGLRLLAPIT AYSQQTRGLL GCIITSLTGR DKNQVEGEVQ VVSTATQSFL ATCVNGVCWT
     VYHGAGSKTL AAPKGPITQM YTNVDQDLVG WPKPPGARSL TPCTCGSSDL YLVTRHADVI
     PVRRRGDSRG SLLSPRPVSY LKGSSGGPLL CPFGHAVGIF RAAVCTRGVA KAVDFVPVES
     METTMRSPVF TDNSSPPAVP QSFQVAHLHA PTGSGKSTKV PAAYAAQGYK VLVLNPSVAA
     TLGFGAYMSK AHGIDPNIRT GVRTITTGAP VTYSTYGKFL ADGGCSGGAY DIIICDECHS
     TDSTTILGIG TVLDQAETAG ARLVVLATAT PPGSVTVPHP NIEEVALSNT GEIPFYGKAI
     PIEAIRGGRH LIFCHSKKKC DELAAKLSGL GINAVAYYRG LDVSVIPTIG DVVVVATDAL
     MTGYTGDFDS VIDCNTCVTQ TVDFSLDPTF TIETTTVPQD AVSRSQRRGR TGRGRRGIYR
     FVTPGERPSG MFDSSVLCEC YDAGCAWYEL TPAETSVRLR AYLNTPGLPV CQDHLEFWES
     VFTGLTHIDA HFLSQTKQAG DNFPYLVAYQ ATVCARAQAP PPSWDQMWKC LIRLKPTLHG
     PTPLLYRLGA VQNEVTLTHP ITKYIMACMS ADLEVVTSTW VLVGGVLAAL AAYCLTTGSV
     VIVGRIILSG RPAIVPDREL LYQEFDEMEE CASHLPYIEQ GMQLAEQFKQ KALGLLQTAT
     KQAEAAAPVV ESKWRALETF WAKHMWNFIS GIQYLAGLST LPGNPAIASL MAFTASITSP
     LTTQSTLLFN ILGGWVAAQL APPSAASAFV GAGIAGAAVG SIGLGKVLVD ILAGYGAGVA
     GALVAFKVMS GEMPSTEDLV NLLPAILSPG ALVVGVVCAA ILRRHVGPGE GAVQWMNRLI
     AFASRGNHVS PTHYVPESDA AARVTQILSS LTITQLLKRL HQWINEDCST PCSGSWLRDV
     WDWICTVLTD FKTWLQSKLL PQLPGVPFFS CQRGYKGVWR GDGIMQTTCP CGAQITGHVK
     NGSMRIVGPK TCSNTWHGTF PINAYTTGPC TPSPAPNYSR ALWRVAAEEY VEVTRVGDFH
     YVTGMTTDNV KCPCQVPAPE FFSEVDGVRL HRYAPACRPL LREEVTFQVG LNQYLVGSQL
     PCEPEPDVAV LTSMLTDPSH ITAETAKRRL ARGSPPSLAS SSASQLSAPS LKATCTTHHV
     SPDADLIEAN LLWRQEMGGN ITRVESENKV VVLDSFDPLR AEEDEREVSV PAEILRKSKK
     FPAAMPIWAR PDYNPPLLES WKDPDYVPPV VHGCPLPPIK APPIPPPRRK RTVVLTESSV
     SSALAELATK TFGSSESSAV DSGTATALPD QASDDGDKGS DVESYSSMPP LEGEPGDPDL
     SDGSWSTVSE EASEDVVCCS MSYTWTGALI TPCAAEESKL PINALSNSLL RHHNMVYATT
     SRSAGLRQKK VTFDRLQVLD DHYRDVLKEM KAKASTVKAK LLSVEEACKL TPPHSAKSKF
     GYGAKDVRNL SSKAVNHIHS VWKDLLEDTV TPIDTTIMAK NEVFCVQPEK GGRKPARLIV
     FPDLGVRVCE KMALYDVVST LPQVVMGSSY GFQYSPGQRV EFLVNTWKSK KNPMGFSYDT
     RCFDSTVTEN DIRVEESIYQ CCDLAPEARQ AIKSLTERLY IGGPLTNSKG QNCGYRRCRA
     SGVLTTSCGN TLTCYLKASA ACRAAKLQDC TMLVNGDDLV VICESAGTQE DAASLRVFTE
     AMTRYSAPPG DPPQPEYDLE LITSCSSNVS VAHDASGKRV YYLTRDPTTP LARAAWETAR
     HTPVNSWLGN IIMYAPTLWA RMILMTHFFS ILLAQEQLEK ALDCQIYGAC YSIEPLDLPQ
     IIERLHGLSA FSLHSYSPGE INRVASCLRK LGVPPLRVWR HRARSVRARL LSQGGRAATC
     GKYLFNWAVK TKLKLTPIPA ASRLDLSGWF VAGYSGGDIY HSLSRARPRW FMLCLLLLSV
     GVGIYLLPNR
//
